Qtick
Sign in

Codexis, Inc. (CDXS) Competitors & Peers

The 5 companies closest to Codexis, Inc. on the factors that matter — each comparable links to its own dossier. Numbers are code-computed, never estimated.

How we identify peers ↗

TickerRelationshipPriceComparables
VRTXPeer$523.91P/E 30.5RSI 70Cap 132.7 B
REGNPeer$808.05P/E 19.4RSI 83Cap 83.2 B
ARGXPeer$866.11P/E 33.0RSI 49Cap 54.2 B
RVMDPeer$206.97RSI 68Cap 44.4 B
CSLLYPeer$23.77P/E 15.4RSI 68Cap 45.5 B

How these relationships were derived

Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.

Confirmed relationships (cited)

Sourced from a public filing or disclosure — each links to its origin.

  • ARCHSupplier

    Own 10-Q customer-concentration disclosure: Arch = 0% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • PFESupplier

    Own 10-Q customer-concentration disclosure: Pfizer = 12% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • XELASupplier

    Own 10-K customer-concentration disclosure: ExelaPharmSciInc = 12% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov
  • NESN.SWSupplier

    Own 10-K customer-concentration disclosure: Nestle = 22% of revenue.

    Confirmed — SEC filing / public disclosuresec.gov

Model-inferred relationships (unverified)

Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.

  • IQVPartner

    IQVIA provides contract clinical research and trial management services (CRO).

    Model-inferred, unverified — treat as a lead, not evidence
  • AMZNSupplier

    Utilizes AWS cloud infrastructure to host genomic sequencing data and clinical trial databases.

    Model-inferred, unverified — treat as a lead, not evidence
  • PFECompetitor

    Competes in development and commercialization of therapeutics for similar indications.

    Model-inferred, unverified — treat as a lead, not evidence